Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 4 I, 2000, Pages 1136-1142

  Littner, Michael R ^a   Ilowite, Jonathan S ^b   Tashkin, Donald P ^b   Friedman, Mitchell ^b   Serby, Charles W ^b   Menjoge, Shailendra S ^b   Witek Jr , Theodore J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; TIOTROPIUM BROMIDE;

ADULT; AGED; ARTICLE; BRONCHITIS; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SPIROMETRY; UPPER RESPIRATORY TRACT INFECTION; VERTIGO; VOMITING;

EID: 0034099036     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.4.9903044     Document Type: Article

References (18)

1. American Thoracic Society. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD). Am. J. Respir. Crit. Care Med. 152(Suppl.):S77-S120.
2. Siafakas, N. M., P. Vermeire, N. B. Pride, P. Paoletti, J. Gibson, P. Howard, J. C. Yernault, M. Decramer, T. Higgenbottom, D. S. Postma, and J. Rees. 1995. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur. Respir. J. 8:1398-1420.
3. Ferguson, G. T., and R. M. Cherniack. 1993. Management of chronic obstructive pulmonary disease. N. Engl. J. Med. 328:1017-1022.
4. Witek, T. J., J. F. Souhrada, C. W. Serby, and B. Disse. 1999. Tiotropium (Ba679): pharmacology and early clinical observations. In S. S. Spector, editor. Anticholinergics in Clinical Practice. Marcel Decker, New York. 137-152.
5. Disse, B., R. Reichl, G. Speck, W. Traunecker, K. L. Rominger, and R. Hammer. 1993. Ba679 Br, a novel anticholinergic bronchodilator: predicted and clinical aspects. Life Sci. 52:537-544.
6. Takahaski, T., M. G. Belvisi, H. Patel, J. K. Ward, S. Tadjkarimi, M. H. Yocub, and P. J. Barnes. 1994. Effect of BA679 BR: a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways. Am. J. Respir. Crit. Care Med. 150:1640-1645.
7. O'Connor, B. J., L. J. Towse, and P. J. Barnes. 1996. Prolonged effect of tiotropium on methacholine-induced bronchoconstriction in asthma. Am. J. Respir. Crit. Care Med. 154:876-880.
8. Maesen, F. P. V., J. J. Smeets, M. A. L. Costongs, F. D. M. Wald, and P. J. D. Cornelissen. 1993. BA 679 BR, a new long-acting antimuscarinic bronchodilator: a pilot dose-escalation study. Eur. Respir. J. 6: 1031-1036.
9. Maesen, F. P. V., J. J. Smeets, T. J. H. Sledsens, F. D. M. Wald, and P. J. G. Cornelissen. 1995. Tiotropium, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Eur. Respir. J. 8:1506-1513.
10. Morris, J. F., A. Koski, W. P. Temple, A. Claremont, and D. R. Thomas. 1998. Fifteen year interval spirometric evaluation of the Oregon predictive equations. Chest 93:123-127.
11. Chodosh, S., J. Flanders, C. W. Serby, D. Hochrainer, and T. J. Witek. 1999. Effective use of HANDIHALER dry powder inhalation system over a broad range of COPD disease severity (abstract). Am. J. Respir. Crit. Care Med. 159:A524.
12. Agresti, A., C. R. Mehta, and N. R. Patel. 1990. Exact inference for contingency tables with ordered categories. J. Am. Stat. Assoc. 85:453-458.
13. Van Andel, A. E., C. Reisner, S. S. Menjoge, and T. J. Witek. 1999. Analysis of inhaled corticosteroid and oral theophylline use among stable COPD patients from 1987 to 1995. Chest 115:703-707.
14. COMBIVENT Inhalation Aerosol Study Group. 1994. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: an 85-day multicenter trial. Chest 105:1411-1419.
15. Wilson, J. D., C. W. Serby, S. S. Menjoge, and T. J. Witek, Jr. 1996. The efficacy and safety of combination bronchodilator therapy. Eur. Respir. Rev. 39:286-289.
16. Van Noord, J. V., T. Bantje, M. Eland, L. Korducki, and P. Cornelissen. 1999. Superior efficacy of tiotropium (TIO) compared to ipratropium (IpBr) as a maintenance bronchodilator in COPD (abstract). Am. J. Respir. Crit. Care Med. 159:A525.
17. Mahler, D. A., J. F. Donahue, R. A. Barbee, M. D. Goldman, N. J. Gross, M. E. Wisniewski, S. W. Yancey, B. A. Zakes, K. A. Rickard, and W. H. Anderson. 1999. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 115:957-965.
18. Van Noord, J. A., J. J. Smeets, F. P. Maesen, L. Korducki, and P. J. Cornelissen. 1998. The onset of spirometric response following once daily inhalation of tiotropium in patients with COPD. Eur. Respir. J. 12:A1S.